This inventor holds 1 USPTO granted patent. Top assignees: National Institute of Health and Medical Research, Université Paris Descartes. Active years: 2018.
Company Filing History:
1 out of 1,853 
1 out of 132 
Years Active: 2018
Title: Olivier Join-Lambert: Innovator in Meningococcal Infection Treatment
Introduction
Olivier Join-Lambert is a notable inventor based in Paris, France. He has made significant contributions to the field of medical research, particularly in the treatment and prevention of meningococcal infections. His innovative work has led to the development of a patent that addresses critical health challenges.
Latest Patents
Olivier Join-Lambert holds a patent concerning the use of an inhibitor of the interaction between type IV pilus-associated protein and CD147. This invention aims to prevent or treat meningococcal bacteraemia and infection. Additionally, it relates to the combined use of such an inhibitor with an anti-bacterial compound, which can be utilized to prevent or treat meningococcal infections. The patent also outlines methods for screening inhibitors of the interaction between type IV pilus-associated protein and CD147.
Career Highlights
Throughout his career, Olivier Join-Lambert has worked with esteemed institutions such as the National Institute of Health and Medical Research and Université Paris Descartes. His research has been pivotal in advancing our understanding of bacterial infections and their treatment.
Collaborations
Olivier has collaborated with notable colleagues, including Xavier Nassif and Sandrine Bourdoulous. These partnerships have enhanced the impact of his research and contributed to the scientific community's knowledge in the field.
Conclusion
Olivier Join-Lambert's innovative work in the treatment of meningococcal infections showcases his dedication to improving public health. His contributions through patents and collaborations highlight the importance of research in combating infectious diseases.